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Abstract 1 
Acanthosis Nigricans (AN) is a common finding in adolescents with obesity. Little 2 
is known about its relevance for cardiovascular (CVS) risk, in particular arterial 3 
stiffening.  We investigated associations between AN, conventional markers of 4 
CVS risk and carotid-radial pulse wave velocity (PWV) in a community sample of 5 
adolescents with obesity aged 12-19 recruited to an obesity trial. AN was present 6 
in 63% of subjects and 43% had severe grading. Presence of AN and severe AN 7 
were associated with BMIz. Presence of AN (but not severity) was associated  8 
with abnormal or fasting hyperinsulinaemia but not after adjustment for BMIz. 9 
PWV data were available for 147 (84% of participants) Severe grade AN was 10 
associated with PWV (co-efficient 0.51, 95% CI 0.13 to 0.89, p = 0.01) but not 11 
when adjusted for BMIz, ethnic grouping and age. In our study presence and 12 
severity of AN offered little additional information on CVS risk beyond the 13 
degree of obesity itself. The relevance of AN for CVS risk should be interpreted 14 
with caution. 15 
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 24 
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Introduction 1 
 2 
Acanthosis nigricans (AN) is a dark, velvety skin pigmentation associated with 3 
obesity(1) frequently encountered in clinical practice in young people with 4 
obesity. Correctly interpreting its relevance and communicating this to patients 5 
and families is important. Studies have identified AN in adolescence as a marker 6 
for type 2 Diabetes Mellitus (DM)(2, 3) and insulin resistance (IR)(4-7) yet it is 7 
unclear whether AN in adolescent obesity is associated with increased 8 
cardiovascular risk separately to risk for diabetes. Whilst attempts to identify 9 
cardiovascular risk by presence of AN in adolescents have been made using 10 
adult-based components of the metabolic syndrome,(6) (7) evidence for 11 
associations between AN and contemporary arterial pathological processes, such 12 
as arterial stiffening, has not been investigated. Pulse Wave Velocity (PWV), is a 13 
non-invasive proxy for arterial stiffness, demonstrated to be a reliable predictor 14 
of future cardiovascular mortality and morbidity in adults,(8, 9) and shown to 15 
correlate with degree of atheroma in adults.(10) Meta-analyses have 16 
demonstrated greater PWV in obese children and adolescents. (11, 12) 17 
 18 
We investigated for associations between AN at the neck and 1) measures of 19 
insulin resistance and 2) PWV using baseline data from a community sample of 20 
obese adolescents (>95th centile Body Mass Index (BMI)) from greater London 21 
recruited into a randomized controlled trial for an obesity intervention.(13)  22 
 23 
Methods 24 
 25 
 4
Subjects were aged 12 to 19 with obesity (>95th centile BMI), recruited from 1 
community sources (GPs, schools, youth groups, self referral) between January 2 
2011 and July 2013 for the HELP trial.(13) Genetic or endocrine causes of 3 
obesity, and chronic illness (including DM types 1 and 2), were excluded. The 4 
Central London ethics committee provided ethics permission.  5 
 6 
Ethnicity was self-reported, grouped as white, black, South Asian or 7 
mixed/other. Pubertal status was self reported using standardized diagrams(14) 8 
and grouped into pre/early (tanner 1 and 2), mid (tanner 3 and 4), late/complete 9 
(5). Family history of type 2 DM (1st degree relative) was recorded. BMI and 10 
waist circumference z-scores (BMIz and waistz) were derived using LMSgrowth 11 
program version 2.69 (Harlow Healthcare, UK) using UK 1990 population 12 
growth data.(15) Fasting insulin and glucose were measured and Homeostatic 13 
Model Assessment Insulin resistance (HOMA-IR) was derived (insulin x 14 
glucose/2).(16) Definitions of metabolic abnormalities were taken from a UK 15 
consensus statement(16) (abnormal HOMA ≥ 4.4, fasting hyperinsulinaemia 16 
using pubertal stage specific cut-offs : >10 mU/L pre/early puberty, >30 mU/L 17 
mid puberty, mU/L>20 late and complete puberty). Information on smoking was 18 
also collected by self-report. Participants with HbA1c or fasting glucose 19 
indicative of diabetes mellitus were excluded. 20 
 21 
AN was measured by appearance and texture at the neck by a single 22 
paediatrician (LH) using a previously reported grading system(17) : absent, 23 
present/mild (limited to base of skull not reaching lateral margins of the neck), 24 
moderate (extending to lateral margins of neck but not visible from front) and 25 
 5
severe (visible from the front). These were dichotomized into two variables for 1 
analysis : 1) AN present or not and 2) severe grade or not (i.e milder grade or not 2 
present).  3 
 4 
A single operator (using tonometry) recorded pulse waveforms at the carotid 5 
and radial pulses. PWV was derived using waveforms, blood pressure and 6 
distances between pulse sites (distance between the carotid and sternal notch, 7 
then sternal notch to the radial pulse via the mid shoulder), using software and 8 
protocolled quality indices (Sphygmocor, AtCor Medical, Sydney Australia). 9 
Blood Pressure was measured at the right arm and averaged 3 times as per 10 
published guidelines.(18) Raw blood pressure was converted into standardized 11 
z-scores (diastolic z and systolic z respectively). A single measurement of PWV 12 
occurred at baseline following a standard operating procedure for all 13 
participants, with quality control adhered to as per the manufacturer’s guidance 14 
(only PWV statistics on wave readings with SDs < 6% mean time and with only 15 
final derived PWV with an SD <10% were accepted). Measurement of PWV was 16 
performed in the supine position, following 30 minutes rest at room 17 
temperature.  18 
 19 
Analysis 20 
STATA version 13 (StataCorp, Texas, USA) was used for analyses. Associations 21 
between. Associations between AN, adiposity measures  and insulin resistance 22 
(as fasting hyperinsuinaemia and abnormal HOMA-IR), were tested using logistic 23 
regression with  odd’s ratios (OR) and linear regression models between AN ,  24 
 6
PWV and adiposity. Multivariable models were then applied to adjust for other 1 
covariables also found to be associated.  2 
 3 
Results 4 
174 subjects were recruited, with even distribution across age groups (mean 5 
15.4 years, SD 2.1 years) with predominance of later stages of puberty (12% 6 
pre/early, 22% mid, 66% late/complete). 62% were female. Ethnicity 7 
composition was white 38%, black 30%, South Asian 21%, mixed/other 11%. 8 
Information on smoking was available for 168 participants, with 120 (70%) 9 
having never smoked and 48 (30%) currently smoking or having smoked 10 
previously. Mean BMIz was 2.80 (SD 0.55).  11 
 12 
Assessment of AN was possible in 173 subjects, with AN present in 109 (63%) 13 
and 75 (43%) of the sample having severe grade AN. Presence of AN was 14 
associated with BMIz (OR 2.12, 95%CI 1.17 to 3.82, p =0.01); and was more 15 
common in all non-white ethnic groups (black OR 29.65, 95% CI 9.38 to 93.75, p 16 
<0.001; South Asian OR 8.47, 95%CI 3.27 to 21.92, p <0.001; mixed OR 5.24, 17 
95%CI 1.73 to 15.85, p < 0.01). There was no association between presence or 18 
severity of AN and sex, age or pubertal stage. Severe grade AN was associated 19 
with BMIz (OR 2.06, 95% CI 1.15 to 3.67, p = 0.02) and was more common in all 20 
non-white ethnic groups compared to white: (black – OR 21.92, 95% CI 8.31 to 21 
57.78 p <0.001; South Asian OR 8.90, 95%CI 3.30 to 23.96, p <0.001; mixed OR 22 
4.15, 95%CI 1.26 to 13.66, p = 0.02). 23 
 24 
 7
Fasting hyperinsulinaemia and abnormal HOMA-IR were present in 34 (24%) 1 
and 35 (20%) of individuals respectively.  Both fasting hyperinsulinaemia and 2 
abnormal HOMA-IR were associated with BMIz and pubertal stage (data not 3 
shown). Univariable models for associations of any or severe grade AN with 4 
fasting hyperinsulinaemia and abnormal HOMA-IR are shown in the table. 5 
Presence of AN was associated with both fasting hyperinsulinaemia and 6 
abnormal HOMA-IR; however this association was attenuated after adjusting for 7 
BMIz and pubertal stage; with. BMIz remaining strongly associated with insulin 8 
resistance in these adjusted models (OR 9.19, 95% CI 3.40 to 25.02, p <0.001, 9 
4.91 for abnormal insulin, OR 4.56, 95% CI 1.91 to 10.87, p = 0.001) 10 
 11 
Presence of AN was positively associated with fasting cholesterol before after 12 
adjustment for BMIz (OR 1.62, 95% CI 1.08 to 2.42, p = 0.01) but not fasting 13 
triglycerides, diastolic z or systolic z blood pressure. Severe AN was positively 14 
associated with diastolic z blood pressure after adjustment for BMIz (OR 1.36, 15 
95% CI 1.03 to 1.81, p = 0.03) but no other cardio-metabolic marker. 16 
 17 
PWV measurements were available for 146 (84%) participants. PWV was 18 
associated with age and ethnicity but not pubertal stage or sex (data not shown). 19 
PWV was associated with BMIz when adjusted for age and ethnicity (co-efficient 20 
0.54, 95% CI 0.19 to 0.88, p < 0.01), but not associated with either systolic or 21 
diastolic blood pressure, nor heart rate (data not shown). Smoking status was 22 
not associated with PWV. Univariable models of associations between presence 23 
of any AN and severe AN and PWV is shown in table. Severe grade AN was 24 
associated with PWV, however, this association was attenuated in a 25 
 8
multivariable model adjusting for BMIz, ethnic grouping and age (see table). 1 
BMIz remained associated with PWV in this multivariable model. 2 
 3 
Discussion 4 
 5 
AN was common in our study population, with 63 % and 43% found to have AN 6 
and Severe AN respectively. There was a positive association between BMIz and 7 
presence of AN (with an increase of 1SD in BMI leading to a doubling in the risk 8 
of AN) consistent with other published studies of AN in adolescent groups.(4-6) 9 
However both presence and severity of AN were poor markers of insulin 10 
resistance when adjusted for BMIz. There were no associations between PWV, as 11 
a proxy for arterial stiffening, after adjusting for BMIz. Our study suggests that 12 
the finding of AN (or severity) in an obese group of adolescents does not provide 13 
additional information about individual cardio-metabolic risk beyond the degree 14 
of obesity itself. Kobaissi et al(7) have similarly reported that presence and 15 
severity of AN poorly predict insulin resistance in adolescent obesity after 16 
adjusting for BMI, albeit in an exclusively Hispanic group. We believe that this is 17 
the first study to examine for a relationship between the presence and severity of 18 
AN, and contemporary measures of arterial stiffness as a proxy for long-term 19 
cardio-metabolic risk.  20 
 21 
There were a number of strengths to our study. We used a community sample 22 
with a mixture of the ethnicities seen in particular in urban areas of the UK, and 23 
also we adjusted for co-variables such as BMIz in regression models. To counter 24 
the challenge of assessing AN in Caucasian individuals, we also used texture as 25 
 9
well as appearance and used a single trained observer. Our study also had a 1 
number of limitations which must be kept in mind. The sample size may have 2 
had insufficient power to detect small effect sizes, especially in multivariable 3 
regression models, and pulse wave data in particular was not complete for all 4 
participants. Although all PWV measurements were consistent with the 5 
manufacturer’s quality control indices (as described above), we measured PWV 6 
only once in each participant at baseline (so as to limit burden on participants 7 
for the bigger trial), meaning that repeated measure variablity can not be 8 
reported for our data. We measured PWV by carotid-radial methodology and 9 
recent evidence has shown that PWV in the context of obesity may vary by 10 
arterial site,(11) thus our findings may not reflect changes at other important 11 
cardio-vascular sites such as the aorta. Given exclusion and screening for DM, 12 
none of our subjects had DM, so our findings cannot be generalized to patients 13 
with established DM, obesity and AN. Our data are also limited in that it is cross-14 
sectional and highlights the need for longitudinal data to more fully examine the 15 
relationship between AN and the development of DM and longer term 16 
cardiovascular risk within groups and individuals. 17 
 18 
In conclusion, the cardio-metabolic relevance of AN is unclear and may offer no 19 
extra information beyond than degree of obesity. It should therefore be 20 
interpreted with caution.  21 
 22 
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Table : Shows A) univariable models with presence of acanthosis nigricans and 
presence of severe acanthosis nigricans as predictors of insulin resistance; B) a 
multivariable, adjusted model (for BMIz and pubertal stage) as predictors of 
acanthosis nigricans and insulin resistance; C) univariable regression model of 
acanthosis nigricans and presence of severe AN as predictors of pulse wave 
velocity; and D) a multivariable, adjusted model (for BMIz, ethnicity and age) of 
presence of severe acanthosis nigricans as a predictor of pulse wave velocity. 
 
 
A. Univariable models of any AN or severe grade AN as predictors of fasting hyperinsulinism and 
abnormal HOMA 
 Any AN present Severe AN present
 N OR (95% 
CI) 
p N OR (95% 
CI) 
p 
Fasting 
hyperinsulinism 
173 2.68 (1.09 
to 6.58) 
0.03* 173 1.88(0.88 
to 4.00) 
0.10 
Abnormal 
HOMA 
173 3.44 (1.34 
to 8.8) 
0.01* 173 1.98 (0.94 
to 4.21) 
0.07 
B. Multivariable model of any AN as a predictor for fasting hyperinsulinism and abnormal HOMA 
(adjusting for BMIz  and pubertal stage)
Fasting 
hyperinsulinism 
173 2.40 (0.85 
to 6.76) 
0.10
Abnormal 
HOMA 
172 2.60 (0.96 
to 7.01) 
0.06
C. Univariable model of Any AN or severe grade AN as predictors of PWV 
 N Beta (95% 
CI) 
p N Beta (95% 
CI) 
p 
PWV 145 0.36 (-0.03 
to 0.76) 
0.07 145 0.51 (0.12 
to 0.89) 
0.01 * 
D. Mutivariable model of Severe AN as a predictor of PWV  (adjusted for BMIz, ethnicity and Age)
PWV  145 0.37 (-0.07 
to 0.80) 
0.10 
 
PWV = pulse wave velocity, BMIz = z-score of Body Mass Index, AN = Acanthosis 
nigricans, HOMA = Homeostatic. N = total number included in each model. 
